Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Debt / NOTE 2.625% 2/1
-
Number of holders
-
16
-
Total 13F principal, excl. options
-
129,026,000
-
Principal change
-
-4,250,000
-
Total reported value, excl. options
-
$129,406,102
-
Value change
-
-$4,815,502
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$0.9985
Significant Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 as of Q3 2021
18 filings reported holding 19459JAA2 - COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 as of Q3 2021.
COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 has 16 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $129,026,000 of principal
.
Largest 10 bondholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC ($37,245,000 of principal), LAZARD ASSET MANAGEMENT LLC ($21,000,000 of principal), STEELHEAD PARTNERS LLC ($21,000,000 of principal), Linden Advisors LP ($11,825,000 of principal), DeepCurrents Investment Group LLC ($11,044,000 of principal), CNH PARTNERS LLC ($7,500,000 of principal), MACQUARIE GROUP LTD ($4,329,000 of principal), CALAMOS ADVISORS LLC ($3,500,000 of principal), Verition Fund Management LLC ($3,213,000 of principal), and GABELLI FUNDS LLC ($3,000,000 of principal).
This table shows the top 16 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.